Concepedia

Masaki Hiraoka

MH

Statistics

Publications

14

Citations

305

H-Index

11

Active since

1986

Affiliations

Bristol-Myers Squibb (Japan)(Current)

Bristol-Myers Squibb (Germany)

Gunma University

Masaki Hiraoka is an author at Bristol-Myers Squibb (Japan) specializing in pharmacology, microbiology, and medicine.

Publications per year

1986–2016

14

Publications

14

Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects

Naomi Yamahira, Charles Frost, Hiroyuki Fukase et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 42 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor

H Nakagawa, Toshiaki Fujita, Shigeki Kubo et al. · Cancer Chemotherapy and Pharmacology · 1996 · 41 citations

Medicine, Pharmacokinetics, Pharmacology +15

Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.

Masaki Hiraoka, SHINJI MASUYOSHI, Susumu Mitsuhashi et al. · The Journal of Antibiotics · 1988 · 37 citations · Full text

Medicine, Microbiology, Pharmacology +14

Comparison between tumor pH and cell sensitivity to heat in RIF-1 tumors.

Masaki Hiraoka, George M. Hahn · PubMed · 1989 · 35 citations

Medicine, Cancer Biology, Oncology +14

MUTAGENICITY TESTS OF ETOPOSIDE AND TENIPOSIDE

H Nakanomyo, Masaki Hiraoka, Mayumi SHIRAYA · The Journal of Toxicological Sciences · 1986 · 27 citations · Full text

Pharmacy, Genetics, Toxicology +16

1–5 of 14